Charcot-Marie-Tooth病市場：依疾病類型、藥物類型、通路和地區分類

Charcot-Marie-Tooth Disease Market, By Disease Type, By Drug Type, By Distribution Channel, By Geography

出版日期: 2026年06月30日 | 出版商:

Coherent Market Insights | 英文 256 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

據估計，2026年Charcot-Marie-Tooth病市場規模為22.715億美元，預計2033年將達到98.965億美元。預計從2026年到2033年，該病市場將以23.4%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	22.715億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	23.40%	2033年市場規模預測：	98.965億美元

Charcot-Marie-Tooth症（CMT）是由影響周邊神經結構和功能的基因突變引起的，這些周圍神經控制著運動和感覺。缺陷基因會導致周邊神經內的神經纖維（軸突）和髓鞘（包裹神經纖維的脂肪層）退化。這會削弱大腦和四肢之間的神經訊號傳遞，導致肌肉萎縮和感覺減退。隨著Charcot-Marie-Tooth症的進展，症狀會從足部和腿部蔓延到手部和手臂。

症狀的嚴重程度（包括腿部、踝關節和足部無力；腿部和足部肌肉量減少；高弓足；錘狀趾；以及行走和跑步能力下降）因人而異，甚至在同一家族內也存在差異。 CMT 的不同類型和亞型是根據突變基因、基因型、神經傳導速度、發病年齡、疾病嚴重程度、臨床症狀和周邊神經損傷情況來確定的。 CMT 的不同類型包括 CMT1、CMT2、CMT3、CMT4、CMTX 和 DICMT。

市場動態

Charcot-Marie-Tooth症（CMT）盛行率的不斷上升是推動市場成長的主要因素之一。例如，根據Medscape於2021年1月發布的數據，CMT的盛行率為每2,500人中就有1人，相當於美國約有12.5萬人患有此病。 CMT 1的發生率為每10萬人中15人，CMT 1A的發生率為每10萬人中10.5人，佔所有CMT 1病例的70%。 CMT 2的發生率為每10萬人中7人。 CMT X患者至少佔所有CMT症候群患者的10-20%。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球Charcot-Marie-Tooth病市場主要公司的概況：公司概況、產品系列、主要亮點、財務表現和市場策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份「全球Charcot-Marie-Tooth病市場報告」旨在為該行業的各種相關人員提供服務，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球Charcot-Marie-Tooth病市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 南非
- 中非
- 北非

第8章：競爭格局概覽

公司簡介
- Addex Therapeutics Ltd.
- Affectis Pharmaceuticals AG
- Genzyme Corp
- Lead Discovery Center GmbH
- Pharnext SA
- Acceleron Pharma
- MedDay Pharmaceuticals
- Bristol-Myers-Squibb Company
- Inflectis Bio Science Health Company
- Helixmith Co., Ltd.
- Neurogene Inc.

第9章

調查方法
關於本公司

簡介目錄

Product Code: CMI4698

Charcot-Marie-Tooth Disease Market is estimated to be valued at USD 2,271.5 Mn in 2026 and is expected to reach USD 9,896.5 Mn by 2033, growing at a compound annual growth rate (CAGR) of 23.4% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 2,271.5 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	23.40%	2033 Value Projection:	USD 9,896.5 Mn

Charcot-marie-tooth (CMT) disease is caused by mutations in the genes that affect the structure and function of peripheral nerves that control movement and sensation. Defective genes can cause the nerve fibers (axons) or myelin sheaths (the fat layer that separates nerve fibers) to degenerate in the peripheral nerves. This weakens the transmission of nerve signals between the brain and limbs, causing muscle atrophy and decreased sensation. As charcot-marie-tooth disease progresses, symptoms will spread from the feet and legs to the hands and arms.

The severity of symptoms (that includes weakness in the legs, ankles, and feet, decreased muscle mass in the legs and feet, high foot arches, curled toes (hammer toes), and decreased walking and running ability, among others) varies from person to person, including between family members. The different types and subtypes of CMT are determined based on the mutant gene, genetic type, nerve conduction velocity, age of onset, disease severity, clinical symptoms, and peripheral nerve injury. The different types of CMT diseases include CMT1, CMT2, CMT3, CMT4, CMTX, and DICMT.

Market Dynamics

Increasing prevalence of charcot-marie tooth disease is one major factor driving the market growth. For instance, according to a data published by the Medscape in January 2021, the prevalence of CMT disease is one in 2,500 population, which is approximately 125,000 people in the U.S. The incidence of CMT 1 is 15 per 100,000 population; the incidence of CMT 1A is 10.5 per 100,000 population, or 70% of CMT 1. The incidence of CMT 2 is seven per 100,000 people. CMT X patients account for at least 10-20% of CMT syndrome patients.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global charcot-marie-tooth disease market based on the following parameters - company highlights, types portfolio, key highlights, financial performance, and market strategies
Key companies covered as a part of this study include Addex Therapeutics Ltd., Affectis Pharmaceuticals AG, Genzyme Corp, Lead Discovery Center GmbH, Pharnext SA, Acceleron Pharma, MedDay Pharmaceuticals, Bristol-Myers-Squibb Company, Inflectis Bio Science Health Company, Helixmith Co., Ltd., and Neurogene Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global charcot-marie-tooth disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global charcot-marie-tooth disease market

Market Segmentation

By Disease Type Insights (Revenue, USD Mn, 2021 - 2033)
CMT 1
CMT 2
CMT 3
Others
By Drug Type Insights (Revenue, USD Mn, 2021 - 2033)
Nonsteroidal anti-inflammatory drugs
Cyclooxygenase-2 inhibitors
Tricyclic antidepressants
Anticonvulsants
Analgesics
Pipeline Drug
By Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- North Africa
- Central Africa
- South Africa
Key Players
Addex Therapeutics Ltd.
Affectis Pharmaceuticals AG
Genzyme Corp
Lead Discovery Center GmbH
Pharnext SA
Acceleron Pharma
MedDay Pharmaceuticals
Bristol-Myers-Squibb Company
Inflectis Bio Science Health Company
Helixmith Co., Ltd.
Neurogene Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Disease Type
- Market Snapshot, By Drug Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Market Opportunity Map

3. Global Charcot-Marie-Tooth Disease Market Insights

Drivers
Restraints
Opportunity
Impact Analysis
Pipeline Analysis
Market Trends
Product Launches
Key Developments
Regulatory Scenario
Collaborations & Acquisitions
Epidemiology
PEST Analysis

4. Global Charcot-Marie-Tooth Disease Market, By Disease Type, 2021 - 2033 (USD Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
CMT 1
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 (USD Million)
CMT 2
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 (USD Million)
CMT 3
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 (USD Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 (USD Million)

5. Global Charcot-Marie-Tooth Disease Market, By Drug Type, 2021 - 2033 (USD Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Nonsteroidal anti-inflammatory drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 (USD Million)
Cyclooxygenase-2 inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 (USD Million)
Tricyclic antidepressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 (USD Million)
Anticonvulsants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 (USD Million)
Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 (USD Million)
Pipeline Drug
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 (USD Million)

6. Global Charcot-Marie-Tooth Disease Market, By Distribution Channel, 2021 - 2033 (USD Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 (USD Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 (USD Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033 (USD Million)

7. Global Charcot-Marie-Tooth Disease Market, By Region, 2021 - 2033 (USD Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Region at Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021-2033, (USD Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021-2033, (USD Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021-2033, (USD Million)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021-2033, (USD Million)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021-2033, (USD Million)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country/Region, 2021-2033, (USD Million)
  - South Africa
  - Central Africa
  - North Africa

8. Competitive Snapshot

Company Profiles
- Addex Therapeutics Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Affectis Pharmaceuticals AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Genzyme Corp
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Lead Discovery Center GmbH
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pharnext SA
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Acceleron Pharma
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- MedDay Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bristol-Myers-Squibb Company
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Inflectis Bio Science Health Company
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Helixmith Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Neurogene Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies